Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2016-10-21
Original SEC Filing: Click here

---

Webplus: SVA/20161021/6-K/2_EX-99.1/000.htm SEC Original: v450829_ex99-1.htm
Sinovac Product Pipeline News Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China BEIJING, China, October 19, 2016 — Sabin-inactivated polio vaccine (sIPV) Varicella vaccine Mr. Weidong Yin, Chairman, President and CEO of Sinovac commented, “We are pleased to provide an update on the advancement of our vaccine pipeline, which underscores our strong R&D capabilities and

---

---

Webplus: SVA/20161021/6-K/1/000.htm SEC Original: v450829_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2016-10-21CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD, HAIDIAN DISTRICT
BEIJING 100085